However, vessel density was not altered in early stage tumors (Figure 4), at time points when the size of shPHD3 LM8 tumors was not significantly increased compared to control tumors, showing that the effect of PHD3 silencing manifests only later during tumor development. The gene discussed is EGLN3; the disease is neoplasm.